Conformational Response to Ligand Binding in Phosphomannomutase2: INSIGHTS INTO INBORN GLYCOSYLATION DISORDER

Схожие документы

• Heterodimerization of Two Pathological Mutants Enhances the Activity of Human Phosphomannomutase2
  по: Andreotti, Giuseppina, et al.
  Опубликовано: (2015)
• Biochemical phenotype of a common disease-causing mutation and a possible therapeutic approach for the phosphomannomutase 2-associated disorder of glycosylation
  по: Andreotti, Giuseppina, et al.
  Опубликовано: (2013)
• A mutant of phosphomannomutase1 retains full enzymatic activity, but is not activated by IMP: Possible implications for the disease PMM2-CDG.
  по: Valentina Citro, et al.
  Опубликовано: (2017-01-01)
• A mutant of phosphomannomutase1 retains full enzymatic activity, but is not activated by IMP: Possible implications for the disease PMM2-CDG
  по: Citro, Valentina, et al.
  Опубликовано: (2017)
• β-Glucose-1,6-Bisphosphate Stabilizes Pathological Phophomannomutase2 Mutants In Vitro and Represents a Lead Compound to Develop Pharmacological Chaperones for the Most Common Disorder of Glycosylation, PMM2-CDG
  по: Maria Monticelli, et al.
  Опубликовано: (2019-08-01)